CHU Reims – Hôpital Maison Blanche
- Address
- 45 Rue Cognacq- Jay, 51092 Reims, France
CHU Reims – Hôpital Maison Blanche
CHU Reims – Hôpital Maison Blanche is a distinguished clinical research center specializing in rheumatology and autoimmune disease management. The center demonstrates particular expertise in evaluating advanced therapeutic strategies for patients with rheumatoid arthritis who have shown inadequate responses to conventional targeted treatments.
- Comparative effectiveness studies of biologic DMARDs including tocilizumab and abatacept
- Treatment optimization for targeted therapy inadequate responders
- Subcutaneous administration protocols for rheumatoid arthritis biologics
The center's research portfolio focuses on improving outcomes for complex rheumatoid arthritis patients through rigorous comparative trials. By conducting superiority trials comparing different biologic agents, the institution contributes valuable evidence to guide treatment selection in patients who have failed one or more targeted therapies, addressing a critical unmet need in modern rheumatology practice.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU Reims – Hôpital Maison Blanche
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pegaspargase Efficacy and Tolerance in Pediatric Acute Lymphoblastic Leukemia Stratified by Risk and Immunophenotype | Assistance Publique Hopitaux De Paris | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pegaspargase | 2 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.